Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Graff (Liège, Belgium), S. Vanwynsberghe (Ghent, Belgium), G. Brusselle (Ghent, Belgium), S. Hanon (Brussels, Belgium), C. Sohy (Namur, Belgium), L. Dupont (Leuven, Belgium), R. Peche (Charleroi, Belgium), A. Michils (Brussels, Belgium), C. Pilette (Brussels, Belgium), G. Joos (Ghent, Belgium), R. Louis (Liège, Belgium), F. Schleich (Liège, Belgium). Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry.. 1114

Member's Comments

No comment yet.

Related content which might interest you: Sesonal variations of severe asthma exacerbations in the US Source: International Congress 2014 – Risk factors for respiratory disease Year: 2014 Characterization of asthma exacerbations in outpatients – National survey Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry Source: Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020 Year: 2020 Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Evaluation of methotrexate in the treatment of severe asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Evaluation of Asthma control and oral corticosteroids in Severe Asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta Source: International Congress 2016 – Asthma management Year: 2016 Acute exacerbations of asthma in Barcelona, the recent experience Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Severe asthma Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD Year: 2014 Severe asthma Source: ERS Lung Science Conference 2016 Year: 2016 Severe asthma Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Severe asthma Source: ISSN=ISSN 1810-6838, ISBN=, page=128 Year: 2006 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Factors associated with irreversible airway obstruction in patients with asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015